Worth Watching Stocks GenMark Diagnostics, Inc.(NASDAQ:GNMK): DHT Holdings, Inc.(NYSE:DHT)

0
1

GenMark Diagnostics, Inc. (GNMK) will report its next earnings on Nov 06 AMC. The company reported the earnings of $-0.2/Share in the last quarter where the estimated EPS by analysts was $-0.19/share. The difference between the expected and actual EPS was $-0.01/share, which represents an Earnings surprise of -5.3%.

Many analysts are providing their Estimated Earnings analysis for GenMark Diagnostics, Inc. and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $-0.16/share. These analysts have also projected a Low Estimate of $-0.18/share and a High Estimate of $-0.14/share.

In case of Revenue Estimates, 8 analysts have provided their consensus Average Revenue Estimates for GenMark Diagnostics, Inc. as 27.41 Million. According to these analysts, the Low Revenue Estimate for GenMark Diagnostics, Inc. is 26.1 Million and the High Revenue Estimate is 28.7 Million. The company had Year Ago Sales of 19.38 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for GNMK to be 23.8%. They are projecting Next Quarter growth of 23.81%. For the next 5 years, GenMark Diagnostics, Inc. is expecting Growth of 35.06% per annum, whereas in the past 5 years the growth was 9.89% per annum.

Some buy side analysts are also providing their Analysis on GenMark Diagnostics, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

GenMark Diagnostics, Inc. closed its last trading session at $5.63 with the loss of -0.89%. The Market Capitalization of the company stands at 332.46 Million. The Company has 52-week high of $8.37 and 52-week low of $3.58. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -0.13% where SMA50 and SMA200 are -2.43% and -14.3% respectively. The Company Touched its 52-Week High on 02/22/19 and 52-Week Low on 12/21/18.

The Relative Volume of the company is 0.19 and Average Volume (3 months) is 260.9 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -53.8%. The Return on Equity (ROE) value stands at -239.2%. While it’s Return on Investment (ROI) value is -68.9%.

While looking at the Stock’s Performance, GenMark Diagnostics, Inc. currently shows a Weekly Performance of 2.57%, where Monthly Performance is -3.79%, Quarterly performance is -6.84%, 6 Months performance is -16.09% and yearly performance percentage is 7.72%. Year to Date performance value (YTD perf) value is 14.81%. The Stock currently has a Weekly Volatility of 3.45% and Monthly Volatility of 4.27%.

DHT Holdings, Inc. (DHT) will report its next earnings on Oct 23 AMC. The company reported the earnings of $-0.06/Share in the last quarter where the estimated EPS by analysts was $-0.07/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 14.3%.

Many analysts are providing their Estimated Earnings analysis for DHT Holdings, Inc. and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $0.61/share. These analysts have also projected a Low Estimate of $0.4/share and a High Estimate of $0.77/share.

In case of Revenue Estimates, 8 analysts have provided their consensus Average Revenue Estimates for DHT Holdings, Inc. as 155.79 Million. According to these analysts, the Low Revenue Estimate for DHT Holdings, Inc. is 125.13 Million and the High Revenue Estimate is 179.95 Million. The company had Year Ago Sales of 85.23 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for DHT to be 469.2%. They are projecting Next Quarter growth of 483.33%. For the next 5 years, DHT Holdings, Inc. is expecting Growth of 55.42% per annum, whereas in the past 5 years the growth was 432% per annum.

Some buy side analysts are also providing their Analysis on DHT Holdings, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

DHT Holdings, Inc. closed its last trading session at $7.38 with the loss of -0.54%. The Market Capitalization of the company stands at 1.06 Billion. The Company has 52-week high of $7.99 and 52-week low of $3.60. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.34% where SMA50 and SMA200 are 2.91% and 26.94% respectively. The Company Touched its 52-Week High on 10/31/19 and 52-Week Low on 02/07/19.

The Relative Volume of the company is 0.56 and Average Volume (3 months) is 2.24 million. The company’s P/E (price to earnings) ratio is 107.94 and Forward P/E ratio of 4.19.

The company shows its Return on Assets (ROA) value of 0.5%. The Return on Equity (ROE) value stands at 1.1%. While it’s Return on Investment (ROI) value is 0.9%.

While looking at the Stock’s Performance, DHT Holdings, Inc. currently shows a Weekly Performance of -1.48%, where Monthly Performance is -7.79%, Quarterly performance is 30.6%, 6 Months performance is 30.84% and yearly performance percentage is 50.72%. Year to Date performance value (YTD perf) value is 87.24%. The Stock currently has a Weekly Volatility of 3.33% and Monthly Volatility of 3.96%.

SHARE